Pregnancy-associated breast cancer (Q57137809)

Acta Obstetricia et Gynecologica Scandinavica

Europe PubMed Central

title

Pregnancy-associated breast cancer (English)

0 references

author name string

Kristjan Skuli Asgeirsson

series ordinal

1

0 references

language of work or name

English

0 references

publication date

February 2011

0 references

published in

0 references

volume

90

0 references

issue

2

0 references

page(s)

158-66

0 references

cites work

Cancer in pregnancy: a review of the literature. Part I.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

The impact of pregnancy on breast cancer outcomes in women<or=35 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Breast cancer trends. Incidence, mortality, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Increasing incidence of pregnancy-associated breast cancer in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Pregnancy-associated breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Maternal and fetal outcome after breast cancer in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Pregnancy and breast cancer: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Breast cancer during pregnancy: quantifying the risk of treatment delay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Breast cancer during pregnancy: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Cancer presenting during pregnancy: radiological perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Radiation dose to organs and tissues from mammography: Monte Carlo and phantom study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Safety of magnetic resonance imaging contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Intensive vs Clinical Follow-up After Treatment of Primary Breast Cancer: 10-Year Update of a Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Contraindications of sentinel lymph node biopsy: are there any really?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Safety of sentinel node biopsy in pregnant patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Cytotoxic therapy and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Taxanes for breast cancer during pregnancy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Tamoxifen as systemic treatment of advanced breast cancer during pregnancy--case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Treatment of breast cancer with trastuzumab during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Trastuzumab in pregnancy associated with poor fetal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Effects of breast-conserving therapy on lactation after pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Conditions in utero and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Survival of breast cancer patients diagnosed during pregnancy or lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X

Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2010.01035.X